Cin 2 3

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-07-13
Clinical Trial Update: An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) [Phase 1, Phase 2]
Phase 1/2 exploratory study evaluating safety and immunogenicity of HPV16+ immunotherapy VB10.16 in women with high-grade cervical intraepit…